Skip to main content
. 2024 Sep 30;7(9):e2436535. doi: 10.1001/jamanetworkopen.2024.36535

Table 2. Estimates of Overall Survival in the RCT and EHR.

Estimate Mortality HR (95% CI) 12-mo Survival probability (95% CI)
Pembrolizumab combination Chemotherapy only
KEYNOTE-189 (ITT) 0.49 (0.38-0.64) 0.69 (0.64-0.74) 0.49 (0.42-0.56)
EHR (ITT) 0.95 (0.78-1.16) 0.60 (0.54-0.65) 0.58 (0.55-0.62)
EHR (PP) 1.15 (0.96-1.37) 0.72 (0.42-1.00) 0.58 (0.18-1.00)

Abbreviations: EHR, electronic health record; HR, hazard ratio; ITT, intention to treat; PP, per protocol.